Search Results - Eggert Stockfleth

Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion by Eggert Stockfleth, Markus V. Heppt, Nathalie Bégeault, Alain Delarue

Connect to this object online.

The Overall Number of Actinic Keratosis Lesions Is Not Predictable by the Number of Visible Lesions: Consequences for Field-Directed Therapies by Eggert Stockfleth, MD PhD, Nathalie Bégeault, MSc, Alain Delarue, MD

Connect to this object online.

Inhibition of Cell Proliferation and Cell Viability by Sinecatechins in Cutaneous SCC Cells Is Related to an Imbalance of ROS and Loss of Mitochondrial Membrane Potential by Jiaqi Zhu, Bernd Gillissen, Dieu Linh Dang Tran, Stefanie May, Claas Ulrich, Eggert Stockfleth, Jürgen Eberle

Connect to this object online.

Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial by Eggert Stockfleth, Thomas Jouary, Francesca Farnetani, Antonio Macaya Pascual, Cecilia De Almeida Agudo, Jean-Jacques Voisard, Nathalie Bégeault, Alain Delarue

Connect to this object online.

An In Vitro Pilot Study Investigating the Antineoplastic Effects of GP-2250 on Cutaneous Squamous Cell Carcinoma Cell Lines: Preliminary Results by Milan Barras, Lutz Schmitz, Chris Braumann, Waldemar Uhl, Marina Skrygan, Marie Buchholz, Thomas Meyer, Eggert Stockfleth, Thomas Müller, Jürgen C. Becker, Thilo Gambichler

Connect to this object online.